1.Polanczyk, G, de Lima, MS, Horta, BL, Biederman, J, Rohde, LA. The worldwide prevalence of ADHD: a systematic review and metaregression analysis. Am J Psychiatry. 2007; 164(6): 942–948.
2.Lopez-Munoz, F, Alamo, C, Quintero-Gutierrez, FJ, Garcia-Garcia, P. A bibliometric study of international scientific productivity in attention-deficit hyperactivity disorder covering the period 1980–2005. Eur Child Adolesc Psychiatry. 2008; 17(6): 381–391.
3.Fayyad, J, De Graaf, R, Kessler, R, etal. Cross-national prevalence and correlates of adult attention-deficit hyperactivity disorder. Br J Psychiatry. 2007; 190: 402–409.
4.Faraone, SV, Biederman, J, Mick, E. The age-dependent decline of attention deficit hyperactivity disorder: a meta-analysis of follow-up studies. Psychol Med. 2006; 36(2): 159–165.
5.Simon, V, Czobor, P, Balint, S, Meszaros, A, Bitter, I. Prevalence and correlates of adult attention-deficit hyperactivity disorder: meta-analysis. Br J Psychiatry. 2009; 194(3): 204–211.
6.Kessler, RC, Adler, L, Barkley, R, etal. The prevalence and correlates of adult ADHD in the United States: results from the National Comorbidity Survey Replication. Am J Psychiatry. 2006; 163(4): 716–723.
7.Faraone, SV, Biederman, J. What is the prevalence of adult ADHD? Results of a population screen of 966 adults. J Atten Disord. 2005; 9(2): 384–391.
8.Schachter, HM, Pham, B, King, J, Langford, S, Moher, D. How efficacious and safe is short-acting methylphenidate for the treatment of attention-deficit disorder in children and adolescents? A meta-analysis. Cmaj. 2001; 165(11): 1475–1488.
9.Faraone, SV, Biederman, J, Roe, C. Comparative efficacy of Adderall and methylphenidate in attention-deficit/hyperactivity disorder: a meta-analysis. J Clin Psychopharmacol. 2002; 22(5): 468–473.
10.Faraone, SV, Biederman, J. Efficacy of Adderall for Attention-Deficit/Hyperactivity Disorder: a meta-analysis. J Atten Disord. 2002; 6(2): 69–75.
11.Faraone, SV, Buitelaar, J. Comparing the efficacy of stimulants for ADHD in children and adolescents using meta-analysis. Eur Child Adolesc Psychiatry. 2010; 19(4): 353–364.
12.Connor, DF, Fletcher, KE, Swanson, JM. A meta-analysis of clonidine for symptoms of attention-deficit hyperactivity disorder. J Am Acad Child Adolesc Psychiatry. 1999; 38(12): 1551–1559.
13.Cheng, JY, Chen, RY, Ko, JS, Ng, EM. Efficacy and safety of atomoxetine for attention-deficit/hyperactivity disorder in children and adolescents-meta-analysis and meta-regression analysis. Psychopharmacology (Berl). 2007; 194(2): 197–209.
14.Hazell, PL, Kohn, MR, Dickson, R, etal. Core ADHD symptom improvement with atomoxetine versus methylphenidate: a direct comparison meta-analysis. J Atten Disord. 2011; 15(8): 674–683.
15.Hanwella, R, Senanayake, M, de Silva, V. Comparative efficacy and acceptability of methylphenidate and atomoxetine in treatment of attention deficit hyperactivity disorder in children and adolescents: a meta-analysis. BMC Psychiatry. 2011; 11: 176.
16.Klassen, A, Miller, A, Raina, P, Lee, SK, Olsen, L. Attention-deficit hyperactivity disorder in children and youth: a quantitative systematic review of the efficacy of different management strategies. Can J Psychiatry. 1999; 44(10): 1007–1016.
17.Bjornstad, G, Montgomery, P. Family therapy for attention-deficit disorder or attention-deficit/hyperactivity disorder in children and adolescents. Cochrane Database Syst Rev. 2005(2): CD005042.
18.Majewicz-Hefley, A, Carlson, JS. A meta-analysis of combined treatments for children diagnosed with ADHD. J Atten Disord. 2007; 10(3): 239–250.
19.Van der Oord, S, Prins, PJ, Oosterlaan, J, Emmelkamp, PM. Efficacy of methylphenidate, psychosocial treatments and their combination in school-aged children with ADHD: a meta-analysis. Clin Psychol Rev. 2008; 28(5): 783–800.
20.Fabiano, GA, Pelham, WE Jr, Coles, EK, etal. A meta-analysis of behavioral treatments for attention-deficit/hyperactivity disorder. Clin Psychol Rev. 2009; 29(2): 129–140.
21.Zwi, M, Jones, H, Thorgaard, C, York, A, Dennis, JA. Parent training interventions for Attention Deficit Hyperactivity Disorder (ADHD) in children aged 5 to 18 years. Cochrane Database Syst Rev. 2011(12): CD003018.
22.Storebo, OJ, Skoog, M, Damm, D, etal. Social skills training for Attention Deficit Hyperactivity Disorder (ADHD) in children aged 5 to 18 years. Cochrane Database Syst Rev. 2011(12): CD008223.
23.Faraone, SV. Using Meta-analysis to Compare the Efficacy of Medications for Attention-Deficit/Hyperactivity Disorder in Youths. P T. 2009; 34(12): 678–694.
24.Faraone, SV, Biederman, J, Spencer, TJ, Aleardi, M. Comparing the efficacy of medications for ADHD using meta-analysis. MedGenMed. 2006; 8(4): 4.
25.Seixas, M, Weiss, M, Muller, U. Systematic review of national and international guidelines on attention-deficit hyperactivity disorder. J Psychopharmacol. 2012; 26(6): 753–765.
26.Ebert, D, Krause, J, Roth-Sackenheim, C. ADHS im Erwachsenenalter - Leitlinien auf der Basis eines Expertenkonsensus mit Unterstützung der DGPPN. Nervenarzt. 2003; 74: 939–946.
27.Nutt, DJ, Fone, K, Asherson, P, etal. Evidence-based guidelines for management of attention-deficit/hyperactivity disorder in adolescents in transition to adult services and in adults: recommendations from the British Association for Psychopharmacology. J Psychopharmacol. 2007; 21(1): 10–41.
29. The Canadian Attention Deficit Hyperactivity Disorder Resource Alliance (CADDRA), Canadian ADHD Practice Guidelines, 2011, CADDRA: Toronto.
30.American Academy of Pediatrics (AAP). ADHD: Clinical Practice Guideline for the Diagnosis, Evaluation, and Treatment of Attention-Deficit/Hyperactivity Disorder in Children and Adolescents. Pediatrics. 2011; 128(5): 1007–1022.
31.Pliszka, S. Practice parameter for the assessment and treatment of children and adolescents with attention-deficit/hyperactivity disorder. J Am Acad Child Adolesc Psychiatry. 2007; 46(7): 894–921.
32.Faraone, SV, Spencer, T, Aleardi, M, Pagano, C, Biederman, J. Meta-analysis of the efficacy of methylphenidate for treating adult attention-deficit/hyperactivity disorder. J Clin Psychopharmacol. 2004; 24(1): 24–29.
33.Maneeton, N, Maneeton, B, Srisurapanont, M, Martin, SD. Bupropion for adults with attention-deficit hyperactivity disorder: meta-analysis of randomized, placebo-controlled trials. Psychiatry Clin Neurosci. 2011; 65(7): 611–617.
34.Verbeeck, W, Tuinier, S, Bekkering, GE. Antidepressants in the treatment of adult attention-deficit hyperactivity disorder: a systematic review. Adv Ther. 2009; 26(2): 170–184.
35.Peterson, K, McDonagh, MS, Fu, R. Comparative benefits and harms of competing medications for adults with attention-deficit hyperactivity disorder: a systematic review and indirect comparison meta-analysis. Psychopharmacology (Berl). 2008; 197(1): 1–11.
36.Castells, X, Ramos-Quiroga, JA, Bosch, R, Nogueira, M, Casas, M. Amphetamines for Attention Deficit Hyperactivity Disorder (ADHD) in adults. Cochrane Database Syst Rev. 2011(6): CD007813.
37.Meszaros, A, Czobor, P, Balint, S, etal. Pharmacotherapy of adult attention deficit hyperactivity disorder (ADHD): a meta-analysis. Int J Neuropsychopharmacol. 2009; 12(8): 1137–1147.
38.Faraone, SV, Glatt, SJ. A comparison of the efficacy of medications for adult attention-deficit/hyperactivity disorder using meta-analysis of effect sizes. J Clin Psychiatry. 2010; 71(6): 754–763.
39.Linderkamp, F, Lauth, G. The Efficacy of Pharmacological versus Psychotherapeutic Therapies in Adults with Attention Deficit/Hyperactivity Disorder (ADHD): An Empirical Meta-Analysis. Verhaltenstherapie. 2011; 21: 229–238.
40.Michielsen, M, Semeijn, E, Comijs, HC, etal. Prevalence of attention-deficit hyperactivity disorder in older adults in The Netherlands. Br J Psychiatry. 2012.
41.Weiss, MD, Gadow, K, Wasdell, MB. Effectiveness outcomes in attention-deficit/hyperactivity disorder. J Clin Psychiatry. 2006; 67(Suppl 8): 38–45.
42.Marcus, SC, Wan, GJ, Kemner, JE, Olfson, M. Continuity of methylphenidate treatment for attention-deficit/hyperactivity disorder. Arch Pediatr Adolesc Med. 2005; 159(6): 572–578.
43.Winterstein, AG, Gerhard, T, Shuster, J, etal. Utilization of pharmacologic treatment in youths with attention deficit/hyperactivity disorder in Medicaid database. Ann Pharmacother. 2008; 42(1): 24–31.
44.Lawson, KA, Johnsrud, M, Hodgkins, P, Sasane, R, Crismon, ML. Utilization patterns of stimulants in ADHD in the Medicaid population: a retrospective analysis of data from the Texas Medicaid program. Clin Ther. 2012; 34(4): 944–956; e4.
45.Safren, SA, Sprich, S, Mimiaga, MJ, etal. Cognitive behavioral therapy vs relaxation with educational support for medication-treated adults with ADHD and persistent symptoms: a randomized controlled trial. Jama. 2010; 304(8): 875–880.